96 related articles for article (PubMed ID: 14514389)
1. [Efficacy of oral bromocriptine in protecting the postpartum systemic lupus erythematosus patients from disease relapse].
Yang XY; Liang LQ; Xu HS; He M; Yao SZ; Zhan ZP; Ye YJ
Zhonghua Nei Ke Za Zhi; 2003 Sep; 42(9):621-4. PubMed ID: 14514389
[TBL] [Abstract][Full Text] [Related]
2. The effects of bromocriptine on preventing postpartum flare in systemic lupus erythematosus patients from South China.
Qian Q; Liuqin L; Hao L; Shiwen Y; Zhongping Z; Dongying C; Fan L; Hanshi X; Xiuyan Y; Yujin Y
J Immunol Res; 2015; 2015():316965. PubMed ID: 25973434
[TBL] [Abstract][Full Text] [Related]
3. Bromocriptine during pregnancy in systemic lupus erythematosus: a pilot clinical trial.
Jara LJ; Cruz-Cruz P; Saavedra MA; Medina G; García-Flores A; Angeles U; Miranda-Limón JM
Ann N Y Acad Sci; 2007 Sep; 1110():297-304. PubMed ID: 17911444
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of bromocriptine in an open label therapeutic trial for systemic lupus erythematosus.
McMurray RW; Weidensaul D; Allen SH; Walker SE
J Rheumatol; 1995 Nov; 22(11):2084-91. PubMed ID: 8596149
[TBL] [Abstract][Full Text] [Related]
5. Bromocriptine in systemic lupus erythematosus: a double-blind, randomized, placebo-controlled study.
Alvarez-Nemegyei J; Cobarrubias-Cobos A; Escalante-Triay F; Sosa-Muñoz J; Miranda JM; Jara LJ
Lupus; 1998; 7(6):414-9. PubMed ID: 9736326
[TBL] [Abstract][Full Text] [Related]
6. Clinical and hormonal response to short-term intermittent versus continuous oral bromocriptine in hyperprolactinemic women.
Parra A; Crespo G; Coria I; Espinosa de los Monteros A
Int J Fertil Menopausal Stud; 1995; 40(2):96-101. PubMed ID: 7599666
[TBL] [Abstract][Full Text] [Related]
7. Effect of bromocriptine on antipsychotic drug-induced hyperprolactinemia: eight-week randomized, single-blind, placebo-controlled, multicenter study.
Lee MS; Song HC; An H; Yang J; Ko YH; Jung IK; Joe SH
Psychiatry Clin Neurosci; 2010 Feb; 64(1):19-27. PubMed ID: 19968833
[TBL] [Abstract][Full Text] [Related]
8. [Analysis of therapeutic outcomes of polycystic ovary syndrome patients with hyperprolactinemia].
Shi YH; Sheng Y; Chen ZJ; Yan JH; Gao Q; Liu H; Ma ZX
Zhonghua Fu Chan Ke Za Zhi; 2008 Apr; 43(4):251-3. PubMed ID: 18843962
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of bromocriptine and chlorotrianisene in preventing postpartum lactation.
Yuen BH; Pendleton HJ; Blair S
Can Med Assoc J; 1977 Oct; 117(8):919-21. PubMed ID: 334356
[No Abstract] [Full Text] [Related]
10. [Sex hormones in female patients with systemic lupus erythematosus].
Jiang JF; Liu YH; Zhang CX
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Jun; 30(3):315-7. PubMed ID: 16045022
[TBL] [Abstract][Full Text] [Related]
11. Prolactin and gonadal hormones during pregnancy in systemic lupus erythematosus.
Jara-Quezada L; Graef A; Lavalle C
J Rheumatol; 1991 Mar; 18(3):349-53. PubMed ID: 1856805
[TBL] [Abstract][Full Text] [Related]
12. Correlation of prolactin serum concentrations with clinical activity and remission in patients with systemic lupus erythematosus. Effect of conventional treatment.
Vera-Lastra O; Mendez C; Jara LJ; Cisneros M; Medina G; Ariza R; Espinoza LR
J Rheumatol; 2003 Oct; 30(10):2140-6. PubMed ID: 14528507
[TBL] [Abstract][Full Text] [Related]
13. Vaginal bromocriptine: pharmacology and effect on serum prolactin in normal women.
Vermesh M; Fossum GT; Kletzky OA
Obstet Gynecol; 1988 Nov; 72(5):693-8. PubMed ID: 3173919
[TBL] [Abstract][Full Text] [Related]
14. Double blind, randomized, placebo controlled clinical trial of methotrexate in systemic lupus erythematosus.
Carneiro JR; Sato EI
J Rheumatol; 1999 Jun; 26(6):1275-9. PubMed ID: 10381042
[TBL] [Abstract][Full Text] [Related]
15. Pregnancy rate following bromocriptine treatment in infertile women with galactorrhea.
Eftekhari N; Mohammadalizadeh S
Gynecol Endocrinol; 2009 Feb; 25(2):122-4. PubMed ID: 19253108
[TBL] [Abstract][Full Text] [Related]
16. Hyperprolactinemia: a 12-year retrospective study at gynecologic endocrinology unit, Siriraj Hospital.
Saejong R; Dangrat C; Techatrisak K; Angsuwatthana S; Rattanachaiyanont M; Tanmahasamut P
J Med Assoc Thai; 2013 Oct; 96(10):1247-56. PubMed ID: 24350404
[TBL] [Abstract][Full Text] [Related]
17. [Hyperprolactinemia in systemic lupus erythematosus. A prospective study of 38 cases].
Smiti Khanfir M; Ben Ghorbel I; Feki M; Lamloum M; Mebazaa A; Miled M; Houman MH
Tunis Med; 2004 Jun; 82(6):512-5. PubMed ID: 15517949
[TBL] [Abstract][Full Text] [Related]
18. A prospective, double-blind, randomized, placebo-controlled clinical trial of bromocriptine in clomiphene-resistant patients with polycystic ovary syndrome and normal prolactin level.
Parsanezhad ME; Alborzi S; Jahromi BN
Int J Fertil Womens Med; 2002; 47(6):272-7. PubMed ID: 12570169
[TBL] [Abstract][Full Text] [Related]
19. Prolactin, estradiol and anticardiolipin antibodies in premenopausal women with systemic lupus erythematosus: a pilot study.
Tiskievicz F; Mallmann ES; Brenol JC; Xavier RM; Spritzer PM
Rev Bras Reumatol; 2011; 51(5):460-4. PubMed ID: 21952998
[TBL] [Abstract][Full Text] [Related]
20. Bromocriptine treatment of systemic lupus erythematosus.
Walker SE
Lupus; 2001; 10(10):762-8. PubMed ID: 11721704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
